NCT03478306View on ClinicalTrials.gov

Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm

PHASE3CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

June 12, 2021

Study Completion Date

June 12, 2021

Conditions
Diabetic RetinopathyMelatoninCircadian DysrhythmiaCircadian Rhythm Sleep Disorder, Unspecified Type
Interventions
DRUG

Melatonin 4 mg Tablet

Participants are randomized into arm 1 or arm2, recieving melatonin or placebo, respectively, for 21 days, followed by 1 week of washout, and then swichting to the contralateral treatment arm.

Trial Locations (1)

2600

Department of Ophthalmology, Rigshospitalet-Glostrup, Glostrup Municipality

All Listed Sponsors
collaborator

Steno Diabetes Center Copenhagen

OTHER

lead

Glostrup University Hospital, Copenhagen

OTHER

NCT03478306 - Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm | Biotech Hunter | Biotech Hunter